MIRA Pharmaceuticals' Lead Drug Candidate Ketamir-2 First Manuscript Accepted for Publication in the Peer-Reviewed Journal Frontiers in Pharmacology
Stock Information for MIRA Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.